Investors / BrightEdge
BrightEdge
Corporate VC
BrightEdge is the innovation and impact investment arm of the American Cancer Society. It invests in and supports entrepreneurs and companies developing cancer care solutions while generating financial returns to sustain ACS's work.
Invests inHealthcare & Biotech
In its own wordscancer carehealth equityimpact investinghealthcareoncologylife sciences
Your fit with BrightEdge
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBrightEdge lists 20 checked portfolio companies on its own site and is named in 9 funding rounds. Its most frequent entry is Series B, 38% of the companies with a known first round. Its largest themes are Healthcare & Biotech (86%), Industrial & Manufacturing (5%) and Fintech (5%). 88% of its companies are based in United States. It invests most often alongside Agent Capital, Casdin Capital and RA Capital.
Counts come from funding rounds that name BrightEdge, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not BrightEdge's whole history. Rounds on record name 8 companies; its own site lists 20. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundBrightEdge does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 25% |
| Series A | 13% |
| Series B | 38% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 1 | 0 |
| '24 | 1 | 0 |
| '25 | 5 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 51th | 20 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 60th | 25% of entries at pre-seed or seed |
| Evidence | 95th | 25% of companies confirmed by a round |
| Sector focus | 95th | 86% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Agent Capital | 3 |
| Casdin Capital | 3 |
| RA Capital | 3 |
| Andreessen Horowitz | 2 |
| Catalio Capital Management | 2 |
| DCVC | 2 |
| GV | 2 |
| General Catalyst | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1890%
- No longer answers00%
- Points to another company210%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 86% | 15% |
| Industrial & Manufacturing | 5% | 7% |
| Fintech | 5% | 12% |
| E-commerce & Marketplaces | 5% | 6% |
Co-investor network
who it backs companies with, and who they back togetherCompare BrightEdge head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with BrightEdge| Date | Company | Stage |
|---|---|---|
| 8 Sept 2026 | Seed | |
| 6 May 2026 | Series C+ | |
| 4 Dec 2025 | Series B | |
| 1 Oct 2025 | Series A | |
| 3 Sept 2025 | Series B | |
| 19 May 2025 | Series C+ | |
| 15 May 2025 | Series B | |
| 15 Feb 2024 | Series C+ |
Round details for BrightEdge
Amounts, full round histories and every co-investor in BrightEdge's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
20 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alpheus Medical is developing a new drug-ultrasound therapy for glioblastoma. | Healthcare & Biotech | May 2025Series B | Page + round | |
| Auron Therapeutics targets cell state plasticity to improve patient outcomes in oncology and inflammatory disease | Healthcare & Biotech | Portfolio page | ||
| Castle Biosciences develops and provides molecular prognostic and diagnostic tests for various diseases, including skin and eye cancers. | Healthcare & Biotech | Portfolio page | ||
| CellCentric develops a drug called inobrodib for the treatment of multiple myeloma and other cancers | Healthcare & Biotech | May 2025Series C+ · 2 rounds | Page + round | |
| Clasp Therapeutics is dedicated to transforming the lives of patients everywhere by mastering the discovery, development and delivery of off-the-shelf precision immunotherapies | Healthcare & Biotech | Portfolio page | ||
| The company is developing a new class of RNA therapeutics to revolutionize cancer therapy. | Healthcare & Biotech | Sept 2026Seed | Funding round | |
| Freenome develops blood-based screening tests to detect cancer at its earliest stages | Healthcare & Biotech | Feb 2024Series C+ | Page + round | |
| Immunitas Therapeutics discovers and develops novel therapeutics for patients with cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Lunit develops medical AI software for cancer detection and precision oncology | Healthcare & Biotech | Portfolio page | ||
| Mercy Bioanalytics develops blood-based tests to detect cancer at its earliest stages using extracellular vesicles and a proprietary platform | Healthcare & Biotech | Sept 2025Series B | Page + round | |
| Modifi provides a platform for business payments and trade finance for global commerce | FintechE-commerce & Marketplaces | Portfolio page | ||
| Naveris develops diagnostic tools for viral-mediated cancer care through precision medicine diagnostics | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Nusano produces radioisotopes and enriched materials for use in healthcare and energy applications | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Paradigm Health provides a platform for clinical trials, offering solutions for trial sponsors and research sites | Healthcare & Biotech | Dec 2025Series B | Page + round | |
| Predicta is building a molecular insights platform for blood cancer care using genomic and immune characterization from blood samples. | Healthcare & Biotech | Oct 2025Series A | Funding round | |
| Signify Bio creates personalized medicines by combining signal peptide engineered control with mRNA encoded design. | Healthcare & Biotech | Portfolio page | ||
| TailorMed provides an end-to-end solution that removes access, affordability, and adherence barriers across the medication journey, connecting patients to resources within the nation’s largest and most diverse network. | Healthcare & Biotech | Portfolio page | ||
| Thatch provides a health benefits platform that allows employees to choose their own care and benefits within a set budget | Healthcare & Biotech | Feb 2023Seed | Funding round |
About this data
site last read 8 Nov 2026- Site
- acsbrightedge.org
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 15 Feb 2023
- Companies checked
- 20
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get BrightEdge's profile as data
Pull BrightEdge's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/acsbrightedge.org
# also
GET /v1/firms/acsbrightedge.org/portfolio
GET /v1/firms/acsbrightedge.org/coinvestors
GET /v1/firms/acsbrightedge.org/news